Reed Siemieniuk
Papers
1
Total Citations
126
H-Index
1
About
Reed Siemieniuk is a leading figure in evidence-based medicine, with a primary focus on perioperative care, thrombosis, and bleeding risk assessment. His major contributions lie in refining the risk-benefit calculus for pharmacological thromboprophylaxis, particularly in high-stakes surgical settings. His highly cited 2017 systematic review and meta-analysis on procedure-specific risks of thrombosis and bleeding in urological cancer surgery (126 citations) provides critical baseline risk estimates that directly inform clinical decision-making. This work helps surgeons and patients navigate the delicate trade-off between preventing life-threatening clots and avoiding dangerous bleeding complications. Beyond this landmark study, Siemieniuk has been instrumental in advancing GRADE methodology and producing rapid, trustworthy clinical guidelines, notably during the COVID-19 pandemic. His research is characterized by rigorous systematic reviews and meta-analyses that translate complex evidence into actionable practice recommendations, making him a pivotal voice in perioperative medicine and evidence synthesis.
Research Focus
Key Achievements
Top Papers
- 1